Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
United Therapeutics Corp. (NASDAQ: UTHR ) said Thursday it has acquired privately held Thymmune Therapeutics. Thymmune is a preclinical biotechnology company developing regenerative thymic cell therapies designed to restore immune function and improve transplant outcomes. Read Also: FDA Approval Positions United Therap
United Therapeutics Corporation (NASDAQ: UTHR ) said Monday that the U.S. Food and Drug Administration (FDA) has granted premarket approval for its LungFX device, marking a significant step in the company’s efforts to increase the number of donor lungs available for transplantation. The approval covers the use of LungF